세계의 바이오테크놀러지 및 제약 서비스 아웃소싱 시장 보고서(2025년)

Biotechnology and pharmaceutical services outsourcing is the strategic practice where life sciences companies delegate specific functions or processes to third-party organizations. This approach allows companies to concentrate on their core competencies, enhance operational efficiency, and reduce costs by utilizing external expertise and infrastructure.

The primary services involved in biotechnology and pharmaceutical outsourcing include consulting, regulatory affairs, product design and development, auditing and assessment, product maintenance, training and education, and others. Consulting provides expert guidance on strategy, operations, compliance, and market entry. These services are applied across therapeutic areas such as oncology, neurology, cardiovascular, and infectious diseases and cater to end users including pharmaceutical and biotech companies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The biotechnology and pharmaceutical services outsourcing market research report is one of a series of new reports from The Business Research Company that provides biotechnology and pharmaceutical services outsourcing market statistics, including biotechnology and pharmaceutical services outsourcing industry global market size, regional shares, competitors with a biotechnology and pharmaceutical services outsourcing market share, detailed biotechnology and pharmaceutical services outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the biotechnology and pharmaceutical services outsourcing industry. This biotechnology and pharmaceutical services outsourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biotechnology and pharmaceutical services outsourcing market size has grown strongly in recent years. It will grow from $66.87 billion in 2024 to $71.87 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth during the historic period can be attributed to the rising demand for therapeutic expertise and global trial design, an increasing number of orphan drug and rare disease trials, the growth of biologics and biosimilar development, greater utilization of laboratory testing and analytical services, and the expansion of virtual biotech firms.

The biotechnology and pharmaceutical services outsourcing market size is expected to see strong growth in the next few years. It will grow to $94.91 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth expected in the forecast period can be attributed to increasing pressure for faster drug approvals, the globalization of clinical research activities, a rise in the volume of clinical trials worldwide, growing outsourcing of phase I-IV trials, and a stronger focus on adaptive and decentralized trials. Key trends during this period include the adoption of cloud-based platforms for real-time collaboration, the use of AI and machine learning in drug discovery and development, advancements in bioinformatics and data analytics, the integration of automation and robotics in laboratory services, and the widespread use of electronic data capture systems.

The increasing activity in clinical research is anticipated to drive the growth of the biotechnology and pharmaceutical services outsourcing market. Clinical research involves systematic investigations using human participants to better understand health conditions and assess the safety and efficacy of medical treatments. This growth in research activity is primarily due to the rising burden of chronic diseases, which calls for the development and evaluation of new therapeutic options to improve patient care. Outsourcing biotechnology and pharmaceutical services facilitates clinical research by offering access to specialized expertise and advanced infrastructure, enabling efficient, cost-effective, and regulatory-compliant trial execution on a global scale. For example, in November 2023, the Association of the British Pharmaceutical Industry, a UK-based trade group, reported a 4.3% rise in the number of industry-led clinical trials in the UK, from 394 in 2021 to 411 in 2022. This increase highlights the expanding demand for outsourced support in clinical development.

Leading companies in the biotechnology and pharmaceutical services outsourcing market are developing advanced tools like cloud-based platforms to support remote access and real-time collaboration. These platforms are internet-based systems that provide users with remote access to computing resources such as storage, software, and processing capabilities, without depending on local infrastructure. For instance, in March 2023, Charles River Labs, a US-based non-clinical contract research organization, introduced Apollo, a cloud-based platform aimed at enhancing toxicology studies. The platform improves client experience by enabling easier access to study data for safety and toxicology assessments. It features self-service options that let users track study progress, review data, and access important documents independently. Notably, it also includes a quoting feature to assist with more accurate and efficient budget planning.

In July 2024, IntegriChain, a software company based in the United States, acquired Federal Compliance Solutions (FCS) for an undisclosed amount. This acquisition strengthens IntegriChain's capabilities in commercialization, revenue operations, and government pricing. Federal Compliance Solutions is a US-based company specializing in outsourcing services for the biotechnology and pharmaceutical sectors.

Major players in the biotechnology and pharmaceutical services outsourcing market are Thermo Fisher Scientific Inc., Boehringer Ingelheim, LabCorp Holdings, IQVIA Inc., ICON plc., Eurofins Scientific SE, Lonza Group Ltd., Syneos Health, Catalent Inc., Charles River Laboratories, Samsung Biologics Co. Ltd., WuXi Biologics, Recipharm AB, Medpace Holdings Inc., Curia Inc., CordenPharma Corp., Parexel International Ltd., Lachman Consultants, Concept Heidelberg GmbH, The Quantic Group Ltd.

North America was the largest region in the biotechnology and pharmaceutical services outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in biotechnology and pharmaceutical services report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the biotechnology and pharmaceutical services Outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biotechnology and pharmaceutical services outsourcing market includes revenues earned by entities by pharmacovigilance, medical writing, data management, analytical testing services, and formulation development. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biotechnology And Pharmaceutical Services Outsourcing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biotechnology and pharmaceutical services outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biotechnology and pharmaceutical services outsourcing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biotechnology and pharmaceutical services outsourcing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Service: Consulting; Regulatory Affairs; Product Design And Development; Auditing And Assessment; Product Maintenance; Training And Education; Other Services
• 2) By Application: Oncology; Neurology; Cardiovascular; Infectious Diseases
• 3) By End-Use: Pharma; Biotech
• Subsegments:
• 1) By Consulting: Strategic Consulting; Market Access Consulting; Commercialization Strategy; Portfolio Management; Technology And Digital Transformation Consulting
• 2) By Regulatory Affairs: Regulatory Submissions; Compliance And Risk Management; Product Registration; Labeling And Packaging Review; Regulatory Intelligence
• 3) By Product Design And Development: Formulation Development; Preclinical Development; Bioprocess Development; Analytical Development; Drug Delivery System Design
• 4) By Auditing And Assessment: Good Manufacturing Practice (GMP) Audits; Good Clinical Practice (GCP) Audits; Quality System Audits; Supplier And Vendor Audits; Risk Assessments
• 5) By Product Maintenance: Lifecycle Management; Change Management; Technical Support; Software And IT System Updates; Compliance Monitoring
• 6) By Training And Education: Regulatory Training; Good Laboratory Practice (GLP) Training; Pharmacovigilance Training; Clinical Trial Training; Quality Management Systems Training
• 7) By Other Services: Intellectual Property Support; Medical Writing; Data Management And Biostatistics; Pharmacovigilance And Drug Safety; Translation And Localization Services
• Companies Mentioned: Thermo Fisher Scientific Inc.; Boehringer Ingelheim; LabCorp Holdings; IQVIA Inc.; ICON plc.; Eurofins Scientific SE; Lonza Group Ltd.; Syneos Health; Catalent Inc.; Charles River Laboratories; Samsung Biologics Co. Ltd.; WuXi Biologics; Recipharm AB; Medpace Holdings Inc.; Curia Inc.; CordenPharma Corp.; Parexel International Ltd.; Lachman Consultants; Concept Heidelberg GmbH; The Quantic Group Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biotechnology And Pharmaceutical Services Outsourcing Market Characteristics

3. Biotechnology And Pharmaceutical Services Outsourcing Market Trends And Strategies

4. Biotechnology And Pharmaceutical Services Outsourcing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Biotechnology And Pharmaceutical Services Outsourcing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Biotechnology And Pharmaceutical Services Outsourcing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Biotechnology And Pharmaceutical Services Outsourcing Market Growth Rate Analysis
• 5.4. Global Biotechnology And Pharmaceutical Services Outsourcing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Biotechnology And Pharmaceutical Services Outsourcing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Biotechnology And Pharmaceutical Services Outsourcing Total Addressable Market (TAM)

6. Biotechnology And Pharmaceutical Services Outsourcing Market Segmentation

• 6.1. Global Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consulting
• Regulatory Affairs
• Product Design And Development
• Auditing And Assessment
• Product Maintenance
• Training And Education
• Other Services
• 6.2. Global Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Neurology
• Cardiovascular
• Infectious Diseases
• 6.3. Global Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharma
• Biotech
• 6.4. Global Biotechnology And Pharmaceutical Services Outsourcing Market, Sub-Segmentation Of Consulting, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Strategic Consulting
• Market Access Consulting
• Commercialization Strategy
• Portfolio Management
• Technology and Digital Transformation Consulting
• 6.5. Global Biotechnology And Pharmaceutical Services Outsourcing Market, Sub-Segmentation Of Regulatory Affairs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Regulatory Submissions
• Compliance and Risk Management
• Product Registration
• Labeling and Packaging Review
• Regulatory Intelligence
• 6.6. Global Biotechnology And Pharmaceutical Services Outsourcing Market, Sub-Segmentation Of Product Design and Development, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Formulation Development
• Preclinical Development
• Bioprocess Development
• Analytical Development
• Drug Delivery System Design
• 6.7. Global Biotechnology And Pharmaceutical Services Outsourcing Market, Sub-Segmentation Of Auditing and Assessment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Good Manufacturing Practice (GMP) Audits
• Good Clinical Practice (GCP) Audits
• Quality System Audits
• Supplier and Vendor Audits
• Risk Assessments
• 6.8. Global Biotechnology And Pharmaceutical Services Outsourcing Market, Sub-Segmentation Of Product Maintenance, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lifecycle Management
• Change Management
• Technical Support
• Software and IT System Updates
• Compliance Monitoring
• 6.9. Global Biotechnology And Pharmaceutical Services Outsourcing Market, Sub-Segmentation Of Training and Education, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Regulatory Training
• Good Laboratory Practice (GLP) Training
• Pharmacovigilance Training
• Clinical Trial Training
• Quality Management Systems Training
• 6.10. Global Biotechnology And Pharmaceutical Services Outsourcing Market, Sub-Segmentation Of Other Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intellectual Property Support
• Medical Writing
• Data Management and Biostatistics
• Pharmacovigilance and Drug Safety
• Translation and Localization Services

7. Biotechnology And Pharmaceutical Services Outsourcing Market Regional And Country Analysis

• 7.1. Global Biotechnology And Pharmaceutical Services Outsourcing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Biotechnology And Pharmaceutical Services Outsourcing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biotechnology And Pharmaceutical Services Outsourcing Market

• 8.1. Asia-Pacific Biotechnology And Pharmaceutical Services Outsourcing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biotechnology And Pharmaceutical Services Outsourcing Market

• 9.1. China Biotechnology And Pharmaceutical Services Outsourcing Market Overview
• 9.2. China Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biotechnology And Pharmaceutical Services Outsourcing Market

• 10.1. India Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biotechnology And Pharmaceutical Services Outsourcing Market

• 11.1. Japan Biotechnology And Pharmaceutical Services Outsourcing Market Overview
• 11.2. Japan Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biotechnology And Pharmaceutical Services Outsourcing Market

• 12.1. Australia Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biotechnology And Pharmaceutical Services Outsourcing Market

• 13.1. Indonesia Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biotechnology And Pharmaceutical Services Outsourcing Market

• 14.1. South Korea Biotechnology And Pharmaceutical Services Outsourcing Market Overview
• 14.2. South Korea Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biotechnology And Pharmaceutical Services Outsourcing Market

• 15.1. Western Europe Biotechnology And Pharmaceutical Services Outsourcing Market Overview
• 15.2. Western Europe Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biotechnology And Pharmaceutical Services Outsourcing Market

• 16.1. UK Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biotechnology And Pharmaceutical Services Outsourcing Market

• 17.1. Germany Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biotechnology And Pharmaceutical Services Outsourcing Market

• 18.1. France Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biotechnology And Pharmaceutical Services Outsourcing Market

• 19.1. Italy Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biotechnology And Pharmaceutical Services Outsourcing Market

• 20.1. Spain Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biotechnology And Pharmaceutical Services Outsourcing Market

• 21.1. Eastern Europe Biotechnology And Pharmaceutical Services Outsourcing Market Overview
• 21.2. Eastern Europe Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biotechnology And Pharmaceutical Services Outsourcing Market

• 22.1. Russia Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biotechnology And Pharmaceutical Services Outsourcing Market

• 23.1. North America Biotechnology And Pharmaceutical Services Outsourcing Market Overview
• 23.2. North America Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biotechnology And Pharmaceutical Services Outsourcing Market

• 24.1. USA Biotechnology And Pharmaceutical Services Outsourcing Market Overview
• 24.2. USA Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biotechnology And Pharmaceutical Services Outsourcing Market

• 25.1. Canada Biotechnology And Pharmaceutical Services Outsourcing Market Overview
• 25.2. Canada Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biotechnology And Pharmaceutical Services Outsourcing Market

• 26.1. South America Biotechnology And Pharmaceutical Services Outsourcing Market Overview
• 26.2. South America Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biotechnology And Pharmaceutical Services Outsourcing Market

• 27.1. Brazil Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biotechnology And Pharmaceutical Services Outsourcing Market

• 28.1. Middle East Biotechnology And Pharmaceutical Services Outsourcing Market Overview
• 28.2. Middle East Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biotechnology And Pharmaceutical Services Outsourcing Market

• 29.1. Africa Biotechnology And Pharmaceutical Services Outsourcing Market Overview
• 29.2. Africa Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Biotechnology And Pharmaceutical Services Outsourcing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biotechnology And Pharmaceutical Services Outsourcing Market Competitive Landscape And Company Profiles

• 30.1. Biotechnology And Pharmaceutical Services Outsourcing Market Competitive Landscape
• 30.2. Biotechnology And Pharmaceutical Services Outsourcing Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Boehringer Ingelheim Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. LabCorp Holdings Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. IQVIA Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. ICON plc. Overview, Products and Services, Strategy and Financial Analysis

31. Biotechnology And Pharmaceutical Services Outsourcing Market Other Major And Innovative Companies

• 31.1. Eurofins Scientific SE
• 31.2. Lonza Group Ltd.
• 31.3. Syneos Health
• 31.4. Catalent Inc.
• 31.5. Charles River Laboratories
• 31.6. Samsung Biologics Co. Ltd.
• 31.7. WuXi Biologics
• 31.8. Recipharm AB
• 31.9. Medpace Holdings Inc.
• 31.10. Curia Inc.
• 31.11. CordenPharma Corp.
• 31.12. Parexel International Ltd.
• 31.13. Lachman Consultants
• 31.14. Concept Heidelberg GmbH
• 31.15. The Quantic Group Ltd.

32. Global Biotechnology And Pharmaceutical Services Outsourcing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biotechnology And Pharmaceutical Services Outsourcing Market

34. Recent Developments In The Biotechnology And Pharmaceutical Services Outsourcing Market

35. Biotechnology And Pharmaceutical Services Outsourcing Market High Potential Countries, Segments and Strategies

• 35.1 Biotechnology And Pharmaceutical Services Outsourcing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Biotechnology And Pharmaceutical Services Outsourcing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Biotechnology And Pharmaceutical Services Outsourcing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer